- Home
- VMAR vs SLRX Comparison
VMAR vs SLRX Comparison
Compare VMAR & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- SLRX
- Stock Information
- Founded
- VMAR 1995
- SLRX N/A
- Country
- VMAR Canada
- SLRX United States
- Employees
- VMAR N/A
- SLRX N/A
- Industry
- VMAR Marine Transportation
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- VMAR Industrials
- SLRX Health Care
- Exchange
- VMAR Nasdaq
- SLRX Nasdaq
- Market Cap
- VMAR 2.3M
- SLRX 2.1M
- IPO Year
- VMAR 2020
- SLRX N/A
- Fundamental
- Price
- VMAR $1.91
- SLRX $2.69
- Analyst Decision
- VMAR Strong Buy
- SLRX
- Analyst Count
- VMAR 1
- SLRX 0
- Target Price
- VMAR $270.00
- SLRX N/A
- AVG Volume (30 Days)
- VMAR 13.6M
- SLRX 6.4M
- Earning Date
- VMAR 01-13-2025
- SLRX 11-14-2024
- Dividend Yield
- VMAR N/A
- SLRX N/A
- EPS Growth
- VMAR N/A
- SLRX N/A
- EPS
- VMAR N/A
- SLRX N/A
- Revenue
- VMAR $2,105,869.00
- SLRX N/A
- Revenue This Year
- VMAR $120.43
- SLRX N/A
- Revenue Next Year
- VMAR N/A
- SLRX N/A
- P/E Ratio
- VMAR N/A
- SLRX N/A
- Revenue Growth
- VMAR N/A
- SLRX N/A
- 52 Week Low
- VMAR $1.30
- SLRX $1.22
- 52 Week High
- VMAR $136.35
- SLRX $7.20
- Technical
- Relative Strength Index (RSI)
- VMAR 51.24
- SLRX 61.15
- Support Level
- VMAR $1.40
- SLRX $2.26
- Resistance Level
- VMAR $2.55
- SLRX $3.53
- Average True Range (ATR)
- VMAR 0.33
- SLRX 0.58
- MACD
- VMAR 0.10
- SLRX 0.11
- Stochastic Oscillator
- VMAR 20.40
- SLRX 20.60
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.